Sarah Brand

Sarah Brand

Unlocking Psychedelics: How Celebrities Are Rewriting the Narrative

From Elon Musk to Amanda Feilding, A Look at the Celebrities Changing the Psychedelic Landscape



In recent years, the world has witness a significant shift in the perception of psychedelics, and this transformation owes much to the influence of celebrities. From Elon Musk’s candid discussions about using ketamine to Amanda Feilding’s advocacy for LSD research, these prominent figures are reshaping how we view these powerful substances. This article explores the profound connection between celebrities in raising the awareness of psychedelics.


The Historical Context:

Before we dive into the celebrity influence, let’s revisit the historical journey on psychedelics. In the mid-20th century, researchers like Humphry Osmond and Timothy Leary explored the therapeutic potential of psychedelics. They conducted studies on the use of substances like LSD and psilocybin for various mental health conditions, including depression and other mental health disorder. These efforts contributed to the emergence of psychedelic-assisted psychotherapy as a field of study. However, the excesses of the 1960s counterculture era and concerns about the safety of psychedelics led to a backlash against these substances. Many governments around the world criminalized their use, which severely limited research and clinical applications.

Growing Body of Evidence:

The accumulating scientific evidence demonstrating the effectiveness of psychedelics in treating conditions such as depression, PTSD, and addiction bolstered their credibility as legitimate therapeutic tools. In the early 2000s, Dr. John Krystal, who is the Chief Psychiatrist at Yale Medicine, has contributed significantly to our understanding of how ketamine can rapidly alleviate symptoms of treatment-resistant depression and other mood disorders. About the same time, Roland Griffiths at Johns Hopkins University conducted groundbreaking studies on the use of psilocybin for anxiety and depression in patients facing life-threatening illnesses.


Breaking the Stigmas:

The turning point came when influential personalities, like Michael Pollan’s 2018 book and later a Netflix special called “How to Change Your Mind” and Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) and Amanda Feilding, known as the “First Lady of LSD” and creator of the Beckley Foundation just to name a few have been instrumental , initiated a crucial dialogue about the therapeutic merits of psychedelics. Their narratives dismantled stigmas and fostered a more open-minded approach to mental health treatment.


The Celebrity Advocacy:

Celebrities possess a unique platform to catalyze change. When they openly discuss their positive experiences with psychedelics, it demystifies these substances and encourages others to consider them as legitimate options for healing. Today, celebrities are speaking out on psychedelics including psilocybin mushrooms, ayahuasca, DMT, ketamine, MDMA and LSD are used by celebrities, such as Mike Tyson, Harry Styles, Sting, Paul McCartney, Kristen Bell, Miley Cyrus, Seth Rogan, and Prince Harry just to name a few.


Ketamine as a Therapy Tool:

Ketamine, once synonymous with party culture, has emerged as a transformative tool in mental health treatment. Celebrities who have discovered its therapeutic benefits are vocal advocates, emphasizing the importance of responsible and clinical use. Recently, Elon Musk discussed his use of ketamine with the Wall Street Journal as a means for treating depression. Musk said he believed ketamine is a better way to deal with depression compared with more widely prescribed antidepressants that are “zombifying” people.

The Psychedelic Renaissance:

Scientific research now backs the therapeutic potential of psychedelics. Johns Hopkins University, Yale University, the University of California, Berkeley, and the Icahn School of Medicine are among the top centers studying psychedelics and psychology. Studies reveal their efficacy in addressing a spectrum of mental health issues. Famous celebrities who endorse these treatments are amplifying calls for further research and access. Silicon Valley and Wall Street executive have reported microdosing on psychedelic to enhance creativity and productivity and reduce stress. Those who have part take in psychedelics included Steve Jobs, Sergey Brin, Peter Thiel and Spencer Shulem just to name a few.


Responsible Usage and Legal Considerations:

A critical reminder: psychedelics should be approached with care and under a medical professional supervision. The legal landscape varies between cities to cities, making it essential to navigate within the framework of medical guidance. Ketamine has long been the only legal off-label medication for treating depression, anxiety, bipolar, PTSD, OCD and other mood disorders. Cities and states are also begun to decriminalize the use of various psychedelics.


Future Prospects:

As the stigma surrounding psychedelics continues to erode, more individuals may share their experiences. This openness has the potential to foster a more compassionate and informed society, offering diverse treatment options for mental health. Additional clinical researches, FDA approvals, legal reforms, increasing public awareness, expanded access and integration into our healthcare practice are likely to play an increasing significant role in combating the mental health crisis and strengthening personal growth in the coming years.



The powerful connection between celebrities and the growing awareness of psychedelics cannot be understated. While they advocate for responsible use, it’s vital for individuals to tread cautiously and seek professional guidance. Innovations in healthcare, such as Telehealth, mail-order prescription and mobile clinics embraced by AVYIA, reflect the evolving landscape of psychedelic therapy. As research advances and legal barriers shift, psychedelics may become an integral part of mental health treatment, offering hope and healing to countless individuals.

More Articles